Pipeline is a scroll reveal landing page built for biotech investor relations. It opens with three live-rendering headline metrics, then progressively discloses pipeline data, financial summaries, and leadership detail as visitors scroll. The design uses a dark terminal palette with phosphor green and alert magenta to create an electric, data-first experience that earns investor trust before asking for anything.
by Rocket studio
Pipeline is a single-page biotech investor relations landing page built around a Stats-First Impact philosophy. It opens with three viewport-scale metrics and reveals each subsequent section only as the visitor scrolls, mimicking staged clinical data disclosure. The Acid Digital color system and monospaced typography create an atmosphere of live, high-stakes data, converting institutional managers, retail shareholders, and sell-side analysts into registered users or deck downloads.
This template is purpose-built for biotech companies that need to communicate trial data, pipeline milestones, and capital decisions to financially sophisticated audiences. It suits teams that want their investor relations page to feel as rigorous as the science behind it.
Most investor relations pages bury the numbers. They open with brand language, logos, and mission statements before showing a single data point. Sophisticated biotech investors, including portfolio managers running concentrated books and analysts building valuation models, need proof before narrative. This template flips that order entirely.
You get a fully structured, single-page investor relations landing page with a progressive scroll reveal architecture. Every section appears only when the visitor reaches it, maintaining tension and focus throughout the experience.




Theme
Data Command
Creative direction
Stats-First Impact
Color system
Acid Digital
Style
Scroll Reveal (Progressive)
Direction
Freemium/Trial
Page Sections
Viewport-scale Metrics Header
Progressive Scroll Reveal Architecture
Animated Pipeline Table
Financial Summary Block
Dual Conversion Path System
Ip, Leadership, and Partnership Sections
Who is the target audience for this landing page?
What does the freemium conversion model include?
Can I use this template without a live data feed?
How does the dual call to action system work?
Is this template suitable for an early-stage company or only later-stage firms?
This template delivers a focused set of components, each designed to match the expectations of data-driven biotech investors.
The page opens cold with three numbers rendered at full viewport scale against void black. No logo preamble, no hero image. Each metric ticks or resolves like a clinical endpoint being unblinded, with a phosphor-green vitals line pulsing beneath them to signal the company is live and active.
Each section materializes only as the visitor scrolls into it, following the staged disclosure logic of clinical data release. This progressive reveal keeps attention sharp and trains readers to expect evidence before explanation at every stage of the page.
The pipeline section assembles row by row, with each molecule sliding in carrying its development phase, therapeutic indication, and current enrollment count. The motion mimics a data monitoring committee breaking the blind, making the pipeline feel like a live feed rather than a static list.
After the pipeline, a crystallizing financial summary presents cash runway, burn rate, and the next financing window. Each figure leads with an oversized number before supporting context loads in, maintaining the proof-first rhythm established in the header.
The primary conversion path is a two-field freemium registration form that appears after the pipeline section has demonstrated data depth. A secondary magenta ghost button floats persistently throughout the page, capturing leads who prefer a downloadable investor deck over platform access.
The latter sections of the page reveal the intellectual property estate, the leadership team, and the partnership map in sequence. Each opens with a single oversized anchor number before context unfolds, keeping the data-first cadence consistent to the end of the page.
| Section | Purpose |
|---|---|
| Live Metrics Header | Opens with three real-time-rendering headline numbers at viewport scale |
| Pipeline Table | Assembles molecule rows with phase, indication, and enrollment data |
| Financial Summary | Crystallizes cash runway, burn rate, and next financing window |
| Freemium Registration Form | Captures email and investor type after pipeline data proves depth |
| IP Estate | Reveals the intellectual property portfolio with an anchor metric |
| Leadership Team | Introduces key personnel with the same data-first reveal pattern |
| Partnership Map | Displays strategic alliances and collaboration context |
| Persistent Deck call to action | Floating magenta ghost button for PDF investor deck download |
The visual identity follows a Data Command theme using the Acid Digital color system. Every color choice carries deliberate meaning, creating a palette that feels like reading a live data feed on a dark terminal at midnight.
The scroll reveal architecture is designed to translate across screen sizes without losing the staged disclosure effect. The layout adapts so that the data-first experience remains intact whether a retail shareholder opens the page on a phone between market hours or a portfolio manager reviews it on a large monitor.
The conversion architecture is intentional and sequenced. Proof comes before the ask, and the ask is deliberately low-friction.
This template sits within the Startup and Launch category with a specific focus on the Biotech Startup subcategory and the Biotech Investor Relations Page niche. It is built for high-stakes moments: coverage initiations, Phase II readouts, financing windows, and catalyst calendar events. The Scroll Reveal (Progressive) template style and Data Command theme combine to create a page that feels distinct from standard investor relations sites.